痰热清联合头孢哌酮/舒巴坦治疗医院获得性肺炎42例临床观察

Clinical Observation on 42 Cases Hospital-aequired Pneumonia Treated by Tanreqing Injection Combined with Cefoperazone/Sulbactam

目的观察痰热清注射液联合头孢哌酮/舒巴坦治疗医院获得性肺炎的临床疗效。方法将80例医院获得性肺炎患者随机分为两组,治疗组42例采用痰热清注射液联合头孢哌酮/舒巴坦治疗,对照组38例单用头孢哌酮/舒巴坦治疗;比较两组治疗前后患者体温、呼吸道症状、肺部口罗音、血常规、胸部X线、细菌学检查等改善情况及治疗中出现的不良反应。结果治疗组总有效率88.09%,对照组总有效率73.68%,有明显差异;两组患者用药治疗过程无明显不良反应。结论痰热清注射液联合头孢哌酮/舒巴坦治疗医院获得性肺炎临床疗效优于单用头孢哌酮/舒巴坦。

Objective To observe the efficacy of Tanreqing Injection combined with Cefoperazone/sulbactam in treatment of hospital - acquired pneumonia. Methods： 80 patients with hospital - acquired pneumonia were randomly divided into two groups. The treatment group （ n = 42） were given Tanreqing Injection and Cefoperazone/sulbactam; the control group（ n =38） were given Cefoperazone/sulbactam. The temperature, symptoms of respiratory tract, crackles of lung, blood routine tests, X - ray of chest and checked of bacteria were measured on two groups before arid after treatment. The adverse effects during treatment were observed too. Results： The effective rate of the treatment group were 88.09%. The control group were 73.68%. There were statistically significant difference between the two groups. Conclusions： The efficacy of hospital - acquired pneumonia treated with Tanreqing Injection combined with Cefoperazone/sulbactam better than treated with Cefoperazone/sulbactam only.